Carteolol indications and usage: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Carteolol}} {{CMG}}; {{AE}} {{SS}} ==Indications and Usage== Ocupress Ophthalmic Solution, 1%, has been shown to be effective in lowering intraocular pressure..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 4: | Line 4: | ||
==Indications and Usage== | ==Indications and Usage== | ||
Ocupress Ophthalmic Solution, 1%, has been shown to be effective in lowering [[intraocular pressure]] and may be used in patients with chronic open-angle [[glaucoma]] and [[intraocular hypertension]]. It may be used alone or in combination with other [[intraocular pressure]] lowering medications.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a11548a0-9c0f-4729-907c-75d8f99a6c85 | publisher = | date = | accessdate = 4 February 2014 }}</ref> | Ocupress Ophthalmic Solution, 1%, has been shown to be effective in lowering [[intraocular pressure]] and may be used in patients with chronic open-angle [[glaucoma]] and [[intraocular hypertension]]. It may be used alone or in combination with other [[intraocular pressure]] lowering medications.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a11548a0-9c0f-4729-907c-75d8f99a6c85 | publisher = | date = | accessdate = 4 February 2014 }}</ref> | ||
==References== | ==References== | ||
Revision as of 18:06, 6 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Indications and Usage
Ocupress Ophthalmic Solution, 1%, has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open-angle glaucoma and intraocular hypertension. It may be used alone or in combination with other intraocular pressure lowering medications.[1]
References
- ↑ "ZEBETA (BISOPROLOL FUMARATE) TABLET [DURAMED PHARMACEUTICALS, INC.]". Retrieved 4 February 2014.